Evidence map›Paper›PMID 37242573›Full record

ArticlePharmaceutics2023

Marine Collagen-Based Bioink for 3D Bioprinting of a Bilayered Skin Model.

Aida Cavallo, Tamer Al Kayal, Angelica Mero, Andrea Mezzetta, Anissa Pisani, Ilenia Foffa, Cecilia Vecoli, Marianna Buscemi, Lorenzo Guazzelli, Giorgio Soldani and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Aida CavalloInstitute of Clinical Physiology, CNR, 54100 Massa, Italy.
Tamer Al KayalInstitute of Clinical Physiology, CNR, 54100 Massa, Italy.
Angelica MeroDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Andrea MezzettaDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-4540-9948
Anissa PisaniInstitute of Clinical Physiology, CNR, 54100 Massa, Italy.
Ilenia FoffaInstitute of Clinical Physiology, CNR, 54100 Massa, Italy.ORCID 0000-0002-4604-0871
Cecilia VecoliInstitute of Clinical Physiology, CNR, 54100 Massa, Italy.
Marianna BuscemiInstitute of Clinical Physiology, CNR, 54100 Massa, Italy.
Lorenzo GuazzelliDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0003-4655-2946
Giorgio SoldaniInstitute of Clinical Physiology, CNR, 54100 Massa, Italy.
Paola LosiInstitute of Clinical Physiology, CNR, 54100 Massa, Italy.ORCID 0000-0002-1350-8626
Istituto di Fisiologia Clinica · ITUniversity of Pisa · ITScuola Superiore Sant'Anna · IT

Funding

Tuscany Region COLLEGAMI project (POR CREO FESR 2014-2020)
6 · The paper itself

Abstract

Marine organisms (i.e., fish, jellyfish, sponges or seaweeds) represent an abundant and eco-friendly source of collagen. Marine collagen, compared to mammalian collagen, can be easily extracted, is water-soluble, avoids transmissible diseases and owns anti-microbial activities. Recent studies have reported marine collagen as a suitable biomaterial for skin tissue regeneration. The aim of this work was to investigate, for the first time, marine collagen from basa fish skin for the development of a bioink for extrusion 3D bioprinting of a bilayered skin model. The bioinks were obtained by mixing semi-crosslinked alginate with 10 and 20 mg/mL of collagen. The bioinks were characterised by evaluating the printability in terms of homogeneity, spreading ratio, shape fidelity and rheological properties. Morphology, degradation rate, swelling properties and antibacterial activity were also evaluated. The alginate-based bioink containing 20 mg/mL of marine collagen was selected for 3D bioprinting of skin-like constructs with human fibroblasts and keratinocytes. The bioprinted constructs showed a homogeneous distribution of viable and proliferating cells at days 1, 7 and 14 of culture evaluated by qualitative (live/dead) and qualitative (XTT) assays, and histological (H&E) and gene expression analysis. In conclusion, marine collagen can be successfully used to formulate a bioink for 3D bioprinting. In particular, the obtained bioink can be printed in 3D structures and is able to support fibroblasts and keratinocytes viability and proliferation.

Indexed as

3D bioprintingalginatebioinkmarine collagenskin model

Identifiers

PMID37242573
PMCPMC10223413
OpenAlexW4366989163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.